[{"Assets_0_Q2_USD":"10919600000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.26","CommonStockSharesIssued_0_Q2_shares":"134600000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.48","EarningsPerShareBasic_2_Q2_USD":"-0.5","EarningsPerShareDiluted_1_Q2_USD":"-0.48","EarningsPerShareDiluted_2_Q2_USD":"-0.5","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"62200000.0","NetIncomeLoss_1_Q2_USD":"-65100000.0","NetIncomeLoss_2_Q2_USD":"-67600000.0","OfficialName":"Perrigo Company plc Ordinary Shares","PaymentsOfDividends_2_Q2_USD":"69600000.0","RevenuesConverted_1_Q2_USD":"1121700000.0","RevenuesConverted_2_Q2_USD":"2196200000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"4849800000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"134600000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"134300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"134600000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"134300000.0","filed":"20220809","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"PERRIGO CO PLC","period":"20220630","qtrs":"0","uom":"USD"}]